Objective-Core2 1 to 6-N-glucosaminyltransferase-I (C2GlcNAcT-I) plays an important role in optimizing the binding functions of several selectin ligands, including P-selectin glycoprotein ligand. We used apolipoprotein E (ApoE)deficient atherosclerotic mice to investigate the role of C2GlcNAcT-I in platelet and leukocyte interactions with injured arterial walls, in endothelial regeneration at injured sites, and in the formation of arterial neointima. Methods and Results-Arterial neointima induced by wire injury was smaller in C2GlcNAcT-I-deficient apoE Ϫ/Ϫ mice than in control apoE Ϫ/Ϫ mice (a 79% reduction in size). Compared to controls, apoE Ϫ/Ϫ mice deficient in C2GlcNAcT-I also demonstrated less leukocyte adhesion on activated platelets in microflow chambers (a 75% reduction), and accumulation of leukocytes at injured areas of mouse carotid arteries was eliminated. Additionally, endothelial regeneration in injured lumenal areas was substantially faster in C2GlcNAcT-I-deficient apoE Ϫ/Ϫ mice than in control apoE Ϫ/Ϫ mice. Endothelial regeneration was associated with reduced accumulation of platelet factor 4 (PF4) at injured sites. PF4 deficiency accelerated endothelial regeneration and protected mice from neointima formation after arterial injury.
P ercutaneous transluminal coronary intervention is a mainstay in the treatment of patients with coronary artery disease. In a great number of patients, however, this intervention results in arterial injury that causes restenosis of the vessel. Arterial restenosis even occurs in the drug-eluting stent area. Restenosis is characterized by a decrease in arterial luminal diameter of 50% or more that results from pathological intimal hyperplasia. 1 Wire-induced neointima formation in the mouse carotid artery is a widely used model for mimicking the pathology of arterial neointima in patients with arterial restenosis. 2 The accumulation of platelets and leukocytes on injured arterial areas is requisite for neointima formation. Immediately after arterial injury, platelets interact with the injured area via many factors, including glycoprotein Ib and glycoprotein IIb/IIIa. 3, 4 On adherence, platelets become activated and express P-selectin, which along with integrins and other platelet-derived factors orchestrates the recruitment of leuko-cytes to the injured site. [5] [6] [7] P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on adherent leukocytes and serves as a platform to recruit more activated platelets. 8 Interactions of platelet P-selectin with PSGL-1 or other P-selectin ligands presented by cells at the injured area contribute to further platelet accumulation. 8 In mice, deletion or blockade of P-selectin or PSGL-1 inhibits this platelet accumulation and leukocyte adhesion, thereby suppressing the formation of arterial neointima. 9 -11 The roles of P-selectin and PSGL-1 in neointima formation have also been validated in other models of vascular injury. 12, 13 PSGL-1 contains sialylated and fucosylated oligosaccharides (O-glycans). 8, 14 This O-glycan structure is crucial for the optimal binding of PSGL-1 to selectins. 15, 16 Core2 1 to 6-N-glucosaminyltransferase-I (C2GlcNAcT-I), an intracellular enzyme in leukocytes, is responsible for the O-glycosylation of PSGL-1. 17 C2GlcNAcT-I is important for the recruitment of Ly-6C hi mouse inflammatory monocytes to arterial vessel walls and the formation of atherosclerotic lesions. 17 However, the role of C2GlcNAcT-I in the regulation of platelet accumulation, leukocyte recruitment, and neointima formation in injured arteries in vivo has yet to be clarified.
We bred C2GlcNAcT-I-deficient mice with apolipoprotein E-deficient atherosclerotic mice to generate double knockout mice (C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ ) and their controls. Using these mice, we investigated the effect of loss of C2GlcNAcT-I on leukocyte and platelet accumulation, endothelial regeneration at injured areas of arteries, and the formation of arterial neointima. Preliminary data from these mice revealed an important role for platelet-leukocyte interactions in endothelial regeneration. To further investigate the molecular mechanisms involved in this process, we used platelet factor 4 (PF4)-deficient mice (PF4 Ϫ/Ϫ ) to study the role of PF4 in endothelial regeneration and neointima formation after arterial injury.
Methods
C2GlcNAcT-I Ϫ/Ϫ 18 and PF4 Ϫ/Ϫ 19 mice were first crossed with C57BL/6J mice for more than 10 times, then bred with apoE Ϫ/Ϫ mice to generate double-knockout mice and their littermate controls. Carotid arteries of these mice were injured using a guide wire according to a protocol approved by the University of Minnesota Institutional Animal Care and Use Committee. Detailed methods are available in the supplemental material (available online at http://atvb.ahajournals.org).
Results

Formation of Injury-Induced Arterial Neointima in C2GlcNAcT-I-Deficient Mice
To determine the role of C2GlcNAcT-I in the formation of arterial neointima, carotid arteries of C2GlcNAcT-I Ϫ/Ϫ / apoE Ϫ/Ϫ mice and littermate C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ mice were injured with a guide wire. Four weeks later, the carotid arteries were excised and processed for analysis.
Injured carotid arteries from C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice exhibited neointima 4 to 6 times smaller than the neointima of C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ mice ( Figure 1a ). Additionally, the number of macrophages ( Figure 1b ) and smooth muscle cells (Figure 1c ) in the neointima of injured arteries from C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice was reduced by 45% and 75%, respectively, compared with those from C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ mice. No difference was found in collagen content in neointima of both types of mice (supplemental Figure I) . Notably, only one-third of arteries from these mice showed neointima and media growth, which was very minor.
Interactions of C2GlcNAcT-I-Deficient Leukocytes With Activated Platelets and Injured Arteries
Using an ex vivo microflow perfusion chamber with a shear stress of 1 dyn/cm 2 , we measured the tethering, rolling, and adherence of wild-type (wt) leukocytes to a surface coated with activated platelets. The number of wt leukocytes that rolled or adhered increased over time. After 5 minutes of perfusion, the number of rolling and adhering wt leukocytes was 800Ϯ70 per mm 2 and 700Ϯ20 per mm 2 , respectively. By contrast, the number of rolling and adhering C2GlcNAcT-Ideficient leukocytes after 5 minutes of perfusion was only 200Ϯ20 per mm 2 and 180Ϯ12 per mm 2 , respectively ( Figure  2a ). C2GlcNAcT-I-deficient leukocytes rolled with higher velocities than wt leukocytes did (data not shown).
We used in vivo mouse models of carotid artery and femoral artery injury and intravital epifluoresence microscopy to examine the interactions of leukocytes and platelets with injured vessel walls. Using a 10ϫ objective, we imaged injured mouse carotid arteries and observed that leukocytes (labeled with rhodamine 6G) rolled and adhered to the injured area in C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ mice. However, in C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice these interactions were almost completely eliminated (Figure 2b ). Using a 40ϫ objective, we imaged rhodamine 6G-labeled platelets and leuko- To further distinguish platelets and leukocytes adherent on injured arteries, we immunostained cross sections of injured arteries using specific markers. At 1 hour after arterial injury in apoE Ϫ/Ϫ mice, the denuded luminal surface was covered with platelets and leukocytes, and many platelets bound to the surface of adherent leukocytes (Figure 2c 
Endothelial Regeneration in the Injured Arteries in C2GlcNAcT-I-Deficient Mice
Reendothelialization is an important deterrent to neointima formation. 20 We used quantitative Evans blue staining to compare the regeneration of endothelial cells on the injured areas of arteries from atherosclerotic mice with and without C2GlcNAcT-I. In the arteries of C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ mice, reendothelialization after wire-induced arterial injury was only 18%, 41%, and 81% at 3, 5, and 7 days, respec-tively; for arteries of C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice, however, reendothelialization was 30%, 61%, and 95% ( Figure  3a ). We also obtained micrographs of cross-sections of injured carotid arteries that were immunostained with anti-CD31 or anti-VE-cadherin. At 3, 5, and 7 days after injury, a greater luminal circumferential area stained positively for these endothelial markers in arteries of C2GlcNAcT-I Ϫ/Ϫ / apoE Ϫ/Ϫ mice than in C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ arteries (Figure 3b ).
PF4 and Reendothelialization of Injured Arteries
Recombinant platelet factor 4 (PF4) inhibits endothelial cell proliferation, 21 so we immunostained the injured arteries for PF4. Nearly all areas where platelets accumulated in the injured arteries of C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ mice stained positively for PF4, and staining on the surface of adherent leukocytes (where platelets bound) was very robust ( Figure  4a ). By contrast, PF4 staining was much weaker in the injured arteries of C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice. This was further confirmed with the results of Western blots. These indicated that PF4 accumulation was much greater in the injured carotid arteries of C2GlcNAcT-I ϩ/ϩ /apoE Ϫ/Ϫ mice than in C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice (Figure 4b ).
To directly address the effect of platelet-released PF4 on endothelial cell proliferation, we used an in vitro model of endothelial wound repair. A sterile pipette tip dragged across confluent endothelial cell monolayers created 1-mm cell-free wounds that recovered nearly completely by Ϸ12 hours (Figure 4c ). This process was not affected by the presence of neutrophils (data not shown). The addition of activated PF4 ϩ/ϩ platelets to the wounded endothelial cell monolayers significantly suppressed the recovery (Figure 4d, left panel) . Furthermore, the suppression of recovery was amplified by adding a mixture of isolated neutrophils and activated PF4 ϩ/ϩ platelets (Figure 4e, left panel) . By contrast, the addition of either activated PF4 Ϫ/Ϫ platelets or a mixture of activated PF4 Ϫ/Ϫ platelets with isolated neutrophils suppressed the recovery of the wounded area with endothelial cells to a much lesser extent than did PF4 ϩ/ϩ platelets or a mixture of both PF4 ϩ/ϩ platelets and neutrophils, respectively (Figure 4d and 4e, right panels, and Figure 4f for quantitative data).
Analyses of 5-bromodeoxyuridine (BrdU) incorporation into endothelial cells showed that the addition of neutrophils to the wounded monolayers did not significantly affect endothelial cell proliferation. However, the addition of activated PF4 ϩ/ϩ platelets inhibited endothelial cell proliferation, and this inhibition was enhanced by the addition of a mixture of activated PF4 ϩ/ϩ platelets with isolated neutrophils. Whenever PF4 Ϫ/Ϫ platelets were added, the suppression of endothelial cell proliferation was significantly reduced (Figure 4g) . These experiments indicated that PF4 from activated platelets, especially in a context of platelet-neutrophil interactions, inhibited endothelial cell proliferation.
Endothelial Regeneration and Neointima Formation in Injured Arteries in PF4-Deficient Mice
We used PF4 Ϫ/Ϫ mice to determine the role of platelet PF4 in endothelial regeneration and neointima formation after arterial injury in vivo. Using the 10ϫ objective of the epifluorescence intravital microscope, we imaged injured carotid mouse arteries and observed leukocyte interactions with the injured vessels. No difference was observed in the number of rolling and adhering leukocytes in the carotid arteries of PF4 Ϫ/Ϫ mice and wt mice (supplemental Figure IIIa) . In the mouse femoral artery injury model, using the 40ϫ objective of the epifluorescence intravital microscope we observed similar platelet accumulations and leukocyte rolling and adhesion on the injured arteries of PF4 Ϫ/Ϫ mice and wt mice (supplemental Figure IV) . In an atherosclerotic background, PF4 immunostaining was performed 1 hour after wire injury of arteries from PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice and PF4 ϩ/ϩ /apoE Ϫ/Ϫ mice. Consistently, PF4 staining was positive on platelets accumulated on injured arteries of PF4 ϩ/ϩ /apoE Ϫ/Ϫ mice and negative on those of PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice (supplemental Figure IIIc) . Platelet accumulation and neutrophil adhesion were observed on injured arteries from both PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ and PF4 ϩ/ϩ /apoE Ϫ/Ϫ mice, and there was no significant difference between the numbers of platelets and neutrophils on the injured arteries from these mice (supplemental Figure  IIIb and IIId to IIIe).
Staining of wire-injured carotid arteries with Evans blue showed that at 5 days after injury, reendothelialization was 65% in arteries of PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice but only 40% in arteries of PF4 ϩ/ϩ /apoE Ϫ/Ϫ mice (Figure 5a ). Relative to PF4 ϩ/ϩ /apoE Ϫ/Ϫ mice, arterial neointima formation after wire injury was significantly reduced by 35% in PF4 Ϫ/Ϫ / apoE Ϫ/Ϫ mice, and the size of the media in injured arteries was also reduced, although the difference was not statistically (Figure 5b ). The number of macrophages and smooth muscle cells in neointima of PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice was reduced by 28% and 25%, respectively, compared to that of PF4 ϩ/ϩ /apoE Ϫ/Ϫ mice (Figure 5c and 5d ).
Discussion
This study demonstrates that C2GlcNAcT-I is critical for the formation of injury-induced arterial neointima in atherosclerotic mice. Compared to control mice, C2GlcNAcT-I Ϫ/Ϫ / apoE Ϫ/Ϫ mice were almost completely incapable of developing significant arterial neointima after wire-induced injury. The inhibition of leukocyte recruitment and rapid endotheli-alization of the vessel wall are important cellular mechanisms for this protection.
The compromised binding of selectin ligands in C2GlcNAcT-I Ϫ/Ϫ mice contributes to the protective effect of C2GlcNAcT-I deficiency on neointima formation. C2GlcNAcT-I deletion reduces neutrophil binding to P-, E-, and L-selectin both in vitro and in vivo. 18, 22, 23 Recently, we also demonstrated decreased binding of monocytes to these selectins. 17 Other C2GlcNAcT-I-modified molecules such as CD34, CD43, and CD44 are speculated to be responsible for the leukocyte homing phenotype of C2GlcNAcT-I Ϫ/Ϫ mice. 24 However, in CD34-or CD43-deficient mice, there is no change in the recruitment of neutrophils and monocytes to inflammatory sites. 25, 26 Also, the binding of CD44 with its major ligand, hyaluronic acid, is not affected by C2GlcNAcT-I deletion. 17 Therefore, C2GlcNAcT-I must affect leukocyte homing through its modification of ligands for P-, E-, and L-selectins.
Our current work illustrates the dynamics of leukocyte interactions with injured arterial areas. Within the first few days of wire-induced injury, the injured arterial area is usually predominated by neutrophils and subsequently by a mixture of neutrophils and monocytes. By approximately 1 week after injury, the injured area is predominated by monocytes (data not shown), consistent with previous studies. 27, 28 It has been well established that monocyte infiltration plays an important role in the formation of neointima. Ly-6C hi monocytes-important contributors to the formation of spontaneous lesions and arterial neointima-express high levels of PSGL-1 and bind selectins with high affinity. 10 Without PSGL-1, Ly-6C hi monocytes cannot be effectively recruited to injured vessel walls, leading to the formation of a much smaller neointima. 10 In C2GlcNAcT-I Ϫ/Ϫ mice, there is a significant defect in the binding function of selectin receptors, including PSGL-1. 17 Consistent with these results, we observed that far fewer monocytes infiltrated the injured vessel wall of C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice relative to apoE Ϫ/Ϫ mice. This may be one of the underlying mechanisms for reduced arterial neointima in C2GlcNAcT-I Ϫ/Ϫ / apoE Ϫ/Ϫ mice.
Neutrophil adhesion to injured arterial areas has been long observed, but the role of neutrophils in neointima formation is uncertain. 27, 29 Some studies have suggested that neutrophils directly contribute to neointima formation. 29, 30 Interestingly, we found that compared to neutrophil-covered injured arterial areas of apoE Ϫ/Ϫ mice, elimination of neutrophils at the injured area in C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ mice promoted endothelial regeneration at the injured area. In addition, injured C2GlcNAcT-I Ϫ/Ϫ /apoE Ϫ/Ϫ arteries attracted fewer platelets and had reduced accumulation of PF4. In vitro experiments indicated that the observed inhibition of endothelial regeneration could be attributed to the increased presence of platelets and platelet-released PF4.
Endothelial recovery after percutaneous transluminal coronary intervention is crucial in the prevention of arterial restenosis. 31 Slow endothelial regeneration leads to an increase in platelet accumulation, leukocyte adherence, and released inflammatory factors from leukocytes and platelets. These pathologies initiate and aggravate the inflammatory response in injured arterial wall. 31 Recombinant PF4 is a well-established potent antiangiogenic factor. 21, 32 Platelets release PF4 in large quantities, 33 but they also release many other factors, including certain angiogenic factors. Consequently, the role of platelet-released PF4 within the context of the total platelet content has been uncertain with regard to endothelial cell proliferation. 21 Our in vitro and in vivo studies are the first to demonstrate that platelet-released PF4 has a significant inhibitory effect on endothelial proliferation, especially in the context of neutrophil-platelet interactions. There are several possible explanations for this. First, as shown in Figure 4a , neutrophils adhering to the injured area provide a platform for more platelets to bind. Without neutrophils, very few platelets and less PF4 accumulate at the injured site. Second, PSGL-1 on neutrophils may interact with P-selectin on platelets to mediate outside-in signaling so as to activate platelets to release more PF4 from their ␣-granules. In P-selectin-deficient mice, platelets that accumulate on the injured arterial area are less compact, 34 indicating that platelets are not fully activated in the absence of P-PSGL-1-mediated platelet-leukocyte interactions. Third, neutrophils may release enzymes to cleave PF4 to optimize its antiangiogenic function or release other factors that synergize with PF4 in its antiangiogenic effect. 35 A variety of PF4-derived peptides inhibit endothelial cell proliferation much more potently than full-length PF4. 36 Neutrophil adhesion at injured areas of PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ arteries was not decreased compared with PF4 ϩ/ϩ /apoE Ϫ/Ϫ arteries. This is consistent with the early observation showing that PF4 is devoid of chemotactic activity for neutrophils. 37 In PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ arteries, there was an increase of endothelial regeneration at injured areas. This may be the predominant underlying mechanism for decreased neointima formation in PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice, but other mechanisms may also be involved. PF4 released from platelets may bind to newly regenerated endothelium and promote monocyte recruitment. Platelet PF4 may bind to RANTES, and these chemokines cooperate to recruitment monocytes to injured vessel wall. 38, 39 Indeed, less accumulation of RANTES was found in the injured area of PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice than PF4 ϩ/ϩ / apoE Ϫ/Ϫ mice (supplemental Figure V) . PF4 also can activate endothelial cells, 40 and activation of newly regenerated endothelial cells on the injured area may be partially responsible for neointima formation in injured arteries of apoE Ϫ/Ϫ mice. In PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice, the level of inflammation of regenerated endothelial cells may be low as a result of PF4 absence. Additionally, protection from arterial injury in PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice may also be attributed to the high level of HDL. Consistent with the results in a previous report, 41 PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice in this study also had a higher level of HDL than PF4 Ϫ/Ϫ /apoE Ϫ/Ϫ mice (data not shown).
Collectively, our data demonstrate that C2GlcNAcT-I is a promising therapeutic target to curb the formation of arterial neointima. Inhibition of C2GlcNAcT-I compromises selectin receptor function, resulting in suppression of leukocyte and platelet accumulation on the vessel wall. In addition, our results reveal an adverse effect of platelet-released PF4 on endothelial regeneration, suggesting that anti-PF4 treatment might have the beneficial effect of inhibiting arterial neointima formation.
